Adjuvant treatment of high-risk melanoma : cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors
Year of publication: |
2022
|
---|---|
Authors: | Wahler, Steffen ; Müller, Alfred ; Fuchs, Sabine ; Schulenburg, Johann-Matthias von der |
Published in: |
Health economics review. - Heidelberg : Springer, ISSN 2191-1991, ZDB-ID 2634483-X. - Vol. 12.2022, 1, Art.-No. 8, p. 1-14
|
Subject: | Melanoma | Cost-effectiveness | Checkpoint-inhibition | Targeted therapy | Adjuvant treatment | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Medizinische Behandlung | Medical treatment | Gesundheitskosten | Health care costs | Gesundheitswesen | Health care system | Theorie | Theory |
Type of publication: | Article |
---|---|
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Other identifiers: | 10.1186/s13561-021-00347-7 [DOI] hdl:10419/285245 [Handle] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Wahler, Steffen, (2022)
-
The science of making better decisions about health : cost-effectiveness and cost-benefit analysis
Russell, Louise, (2014)
-
Schwander, Bjoern, (2014)
- More ...
-
Wahler, Steffen, (2022)
-
Wahler, Steffen, (2022)
-
Wahler, Steffen, (2022)
- More ...